Intentional Inadvertent 1. Iatrogenic (a) Suppressive thyroxine dose in thyroid cancer (b) Excessive thyroxine dose to shrink goiter (c) Patient’s insistence on higher thyroid hormone dose 2. Factitious (a) Surreptitious ingestion of thyroid hormone to feign…
Fig. 1.1 Adapted from Neurosurg Focus 29(4):E15, Fleseriu, M., Delashaw, J.B., and Cook, D.M. Acromegaly: a review of current medical therapy and new drugs on the horizon, page 3, Copyright…
Fig. 6.1 Pituitary macroadenoma (arrows) abutting the optic chiasm superiorly on contrast-enhanced coronal (a) and sagital (b) MRIs Other evaluations during his hospitalization revealed evidence of cardiomyopathy that was attributed…
© Springer Science+Business Media New York 2015Terry F. Davies (ed.)A Case-Based Guide to Clinical Endocrinology10.1007/978-1-4939-2059-4_5 5. Introduction David S. Cooper1 (1) Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, 1830 E. Monument…
Classification, Use, and Toxicity of Clinically useful Chemotherapy and molecular Targeted Therapy Anis Toumeh Roland T. Skeel I. CLASSES OF DRUGS Chemotherapeutic agents, whether classical or molecular targeted, are customarily…
Side Effects of Immune Therapy John E. Janik I. INTRODUCTION The toxicity profile of immune-based therapies has in the past typically been related to the dose and schedule of the…
Side Effects of Chemotherapy Janelle M. Tipton I. INTRODUCTION Supportive care of the patient receiving chemotherapy continues to gain recognition as an equally important component of definitive therapy. Advances have…
Metastatic Cancer of Unknown Origin Christophe Massard I. INTRODUCTION Carcinomas of unknown primary site (CUP) are a group of heterogeneous tumors that share the unique clinical characteristic of metastatic diseases…
Multiple Myeloma, Other Plasma Cell Disorders, and Primary Amyloidosis Rachid Baz Mohamad A. Hussein I. INTRODUCTION A. Types of plasma cell dyscrasias Plasma cell dyscrasias represent a heterogeneous group of…
Non-Hodgkin Lymphoma Catherine Lai Mark Roschewski Wyndham H. Wilson I. INTRODUCTION Non-Hodgkin lymphomas (NHLs) are a diverse group of malignant neoplasms involving lymphocytes of B-cell, T-cell, or natural killer (NK)-cell…
